Cushing's Syndrome I

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Cushing's Syndrome I trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT05307328

SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome

This is a randomized, placebo-controlled, study of SPI-62 in subjects with ACTH-dependent Cushing's syndrome caused by a non-adrenal tumor. Subjects will receiv…

United States26 participantsStarted 2022-09-01

Treatment: SPI-62, Placebo